Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes

Pflugers Arch. 2015 Jul;467(7):1431-1443. doi: 10.1007/s00424-014-1581-4. Epub 2014 Aug 2.

Abstract

Although beat-to-beat variability (short-term variability, SV) of action potential duration (APD) is considered as a predictor of imminent cardiac arrhythmias, the underlying mechanisms are still not clear. In the present study, therefore, we aimed to determine the role of the major cardiac ion currents, APD, stimulation frequency, and changes in the intracellular Ca(2+) concentration ([Ca(2+)]i) on the magnitude of SV. Action potentials were recorded from isolated canine ventricular cardiomyocytes using conventional microelectrode techniques. SV was an exponential function of APD, when APD was modified by current injections. Drug effects were characterized as relative SV changes by comparing the drug-induced changes in SV to those in APD according to the exponential function obtained with current pulses. Relative SV was increased by dofetilide, HMR 1556, nisoldipine, and veratridine, while it was reduced by BAY K8644, tetrodotoxin, lidocaine, and isoproterenol. Relative SV was also increased by increasing the stimulation frequency and [Ca(2+)]i. In summary, relative SV is decreased by ion currents involved in the negative feedback regulation of APD (I Ca, I Ks, and I Kr), while it is increased by I Na and I to. We conclude that drug-induced effects on SV should be evaluated in relation with the concomitant changes in APD. Since relative SV was decreased by ion currents playing critical role in the negative feedback regulation of APD, blockade of these currents, or the beta-adrenergic pathway, may carry also some additional proarrhythmic risk in addition to their well-known antiarrhythmic action.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Action Potentials*
  • Animals
  • Calcium / metabolism
  • Cardiotonic Agents / pharmacology
  • Cells, Cultured
  • Chromans / pharmacology
  • Dogs
  • Feedback, Physiological
  • Female
  • Heart Ventricles / cytology*
  • Ion Channels / antagonists & inhibitors
  • Ion Channels / metabolism*
  • Ion Transport
  • Isoproterenol / pharmacology
  • Lidocaine / pharmacology
  • Male
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / physiology*
  • Nisoldipine / pharmacology
  • Phenethylamines / pharmacology
  • Potassium Channel Blockers / pharmacology*
  • Sulfonamides / pharmacology
  • Tetrodotoxin / pharmacology
  • Veratridine / pharmacology

Substances

  • Cardiotonic Agents
  • Chromans
  • HMR 1556
  • Ion Channels
  • Phenethylamines
  • Potassium Channel Blockers
  • Sulfonamides
  • Tetrodotoxin
  • Nisoldipine
  • Veratridine
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • Lidocaine
  • Isoproterenol
  • dofetilide
  • Calcium